(Q33983917)

30 July 2017

title

Which patients benefit from hemodialysis therapy in hepatorenal syndrome? (English)

1 reference

30 July 2017

1 reference

7

Guido Gerken

1 reference

30 July 2017

Oliver Witzke

1

1 reference

30 July 2017

Markus Baumann

2

1 reference

30 July 2017

Daniel Patschan

3

1 reference

30 July 2017

Susann Patschan

4

1 reference

30 July 2017

Anna Mitchell

5

1 reference

30 July 2017

Ulrich Treichel

6

1 reference

30 July 2017

Thomas Philipp

8

1 reference

30 July 2017

Andreas Kribben

9

1 reference

30 July 2017

language of work or name

1 reference

1 December 2004

1 reference

Journal of Gastroenterology and Hepatology

30 July 2017

published in

1 reference

30 July 2017

volume

19

1 reference

30 July 2017

issue

12

1 reference

30 July 2017

page(s)

1369-1373

1 reference

New treatments for hepatorenal syndrome.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03471.X

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03471.X

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03471.X

Reversibility of hepatorenal syndrome in an anuric patient with child C cirrhosis requiring haemodialysis for 7 weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03471.X

Liver transplantation for dialysis dependent hepatorenal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03471.X

The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03471.X

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03471.X

Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03471.X

10.1111/J.1440-1746.2004.03471.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference